Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study
Pain Research and Management · 2023
DOI: 10.1155/2023/7708982 ↗Kurz gefasst
Pragmatische Studie in der Zeitschrift Pain Research and Management, 2023. Verfasst von Guy H Hans und 8 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Pain Center, Antwerp University Hospital (UZA), Edegem, Belgium. Hauptthemen laut MEDLINE: Capsaicin, Neuralgia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Belgian Health Care Knowledge Centre.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
A qualitative evaluation study of the prematurely terminated PrEgabalin Lidocaine Capsaicin Neuropathic Pain (PELICAN) study was performed. The PELICAN study aimed to examine pain management for localized neuropathic pain (LNP), as epidemiological figures have shown a high percentage of LNP patients in Belgium. The study compared systemic and topical medications according to pain relief, adverse effects, and several measures of quality of life.
Objective
Achieving better study patient recruitment through qualitative research. To investigate and determine the causes of the observed recruitment problems in the PELICAN study, pain centers involved in the study as well as nonrecruiting pain centers were included. Furthermore, it aimed to highlight the positive and negative lessons learned from the conducted study and the number of obstacles the team had to overcome.
Methods
A qualitative study, using a mixed methods approach, was performed. Multiple pain centers in Belgium completed an online survey, after which a structured interview was conducted to elaborate the responses in more detail. The broad topics of these meetings were feedback about the study, reviewing survey answers, and actions undertaken to enhance recruitment.
Results
Different factors contributed to the low recruitment rate in the PELICAN study, such as limited and late referral from the general practitioners to the Belgian pain centers, insufficient internal referrals from nonpain specialists, lack of specific expertise on LNP in some centers, scarcity of staff, limited reimbursement to administer complex analgesic schemes, overestimation of the patient population, and the reluctance of patients to participate in pain research. Additionally, shortcomings in the implemented study design and the need for more logistical investments were identified.
Conclusion
The findings of the qualitative study demonstrate the need for further, more varied LNP research in Belgium, not limited to pharmacological studies. It also sheds important light on the recruitment obstacles that may be faced during these studies. Future studies could support this research by offering better proposals for feasibility and recruitment, for instance, by designing and conducting a compelling pilot study or applying social media during the recruitment phase. Clinical Trials. This trial is registered with NCT03348735. EUDRACT number 2018-003617-17.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Multidisciplinary Pain Center, Antwerp University Hospital (UZA), Edegem, Belgium.
- ASTARC, University of Antwerp (UA), Antwerp, Belgium.
- Clinical Trial Center (CTC), Antwerp University Hospital (UZA), Edegem, Belgium.
- StatUa, Center for Statistics, University of Antwerp (UA), Antwerp, Belgium.
- Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Hospital Oost-Limburg, Genk, Belgium.
- Multidisciplinary Pain Center, Vivalia, Libramont, Belgium.
ORCID-Profile: Guy H Hans, Ella Roelant, Iris Verhaegen, Elke Smits
Förderung
- Belgian Health Care Knowledge Centre
Zitieren
APA
Hans, G. H., Almeshal, D., Vanlommel, L., Roelant, E., Verhaegen, I., Smits, E., Van Boxem, K., Fontaine, R., & Investigators Team, T. P. (2023). Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study. Pain Research and Management. https://doi.org/10.1155/2023/7708982
Vancouver
Hans GH, Almeshal D, Vanlommel L, Roelant E, Verhaegen I, Smits E, et al. Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study. Pain Research and Management. 2023. doi:10.1155/2023/7708982
BibTeX
@article{Hans2023,
author = {Hans, Guy H and Almeshal, Dima and Vanlommel, Lotte and Roelant, Ella and Verhaegen, Iris and Smits, Elke and Van Boxem, Koen and Fontaine, Robert and Investigators Team, The Pelican},
title = {Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study},
journal = {Pain Research and Management},
year = {2023},
doi = {10.1155/2023/7708982}
}
EUVIMED